Literature DB >> 16580450

Antagonizing reactive oxygen by treatment with a manganese (III) metalloporphyrin-based superoxide dismutase mimetic in cardiac transplants.

Vani Nilakantan1, Xianghua Zhou, Gail Hilton, Yang Shi, John E Baker, Ashwani K Khanna, Galen M Pieper.   

Abstract

OBJECTIVE: Oxidative stress might be an important factor contributing to injury during alloimmune activation. Herein, we evaluated the efficacy of a superoxide dismutase mimetic, manganese (III) tetrakis (1-methyl-4-pyridyl) porphyrin pentachloride (MnTmPyP), on cytokine gene expression and apoptotic signaling in a rat model of cardiac transplantation.
METHODS: Lewis-->Lewis (isografts) or Wistar-Furth-->Lewis (allografts) heterotopic rat transplants without and with treatment with MnTmPyP were used. Reactive oxygen formation was determined on the basis of dihydroethidine fluorescence and lucigenin-enhanced chemiluminescence. In situ graft function was determined by means of sonomicrometry. Inflammatory cytokine, proapoptotic, and antiapoptotic gene expression at either postoperative day 4 (early rejection) or postoperative day 6 (late rejection) was determined by means of reverse transcriptase polymerase chain reaction.
RESULTS: An increased production of reactive oxygen in allografts was inhibited to isograft control levels by MnTmPyP. MnTmPyP restored either the percentage of fractional shortening, the distended diastolic and systolic myocardial segment lengths, or both in allografts. Of the increases in cytokine and proapoptotic gene expression in allografts, only interleukin 6 was decreased by MnTmPyP. MnTmPyP inhibited antiapoptotic gene expression (Bcl-2 and Bcl-xL) during early rejection but restored expression at later stages. The increase in activated caspase-3 levels in allografts was inhibited by MnTmPyP.
CONCLUSIONS: The mechanism of the beneficial effect of MnTmPyP on graft function appear related, in part, to scavenging O2*- and by decreasing apoptotic signaling rather than an effect on inflammatory cytokine gene expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16580450     DOI: 10.1016/j.jtcvs.2005.11.015

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  8 in total

Review 1.  Hydroethidine- and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truth.

Authors:  Jacek Zielonka; B Kalyanaraman
Journal:  Free Radic Biol Med       Date:  2010-01-29       Impact factor: 7.376

2.  Differences in left ventricular cardiomyocyte loss induced by chronic intermittent hypoxia between spontaneously hypertensive and Wistar-Kyoto rats.

Authors:  Tsung-I Chen; Ching-Jung Lai; Chien-Ju Hsieh; Ke-Li Tsai; Kun-Ta Yang
Journal:  Sleep Breath       Date:  2010-12-07       Impact factor: 2.816

3.  MnTMPyP, a superoxide dismutase/catalase mimetic, decreases inflammatory indices in ischemic acute kidney injury.

Authors:  Jordan Mortensen; Brian Shames; Christopher P Johnson; Vani Nilakantan
Journal:  Inflamm Res       Date:  2010-12-12       Impact factor: 4.575

Review 4.  Potential therapeutic benefits of strategies directed to mitochondria.

Authors:  Amadou K S Camara; Edward J Lesnefsky; David F Stowe
Journal:  Antioxid Redox Signal       Date:  2010-08-01       Impact factor: 8.401

Review 5.  The complex role of iNOS in acutely rejecting cardiac transplants.

Authors:  Galen M Pieper; Allan M Roza
Journal:  Free Radic Biol Med       Date:  2008-02-07       Impact factor: 7.376

6.  MnTMPyP, a cell-permeant SOD mimetic, reduces oxidative stress and apoptosis following renal ischemia-reperfusion.

Authors:  Huan Ling Liang; Gail Hilton; Jordan Mortensen; Kevin Regner; Christopher P Johnson; Vani Nilakantan
Journal:  Am J Physiol Renal Physiol       Date:  2008-12-17

7.  20-HETE-mediated cytotoxicity and apoptosis in ischemic kidney epithelial cells.

Authors:  Vani Nilakantan; Cheryl Maenpaa; Guangfu Jia; Richard J Roman; Frank Park
Journal:  Am J Physiol Renal Physiol       Date:  2008-01-02

8.  Manganese porphyrin reduces renal injury and mitochondrial damage during ischemia/reperfusion.

Authors:  Hamida Saba; Ines Batinic-Haberle; Shankar Munusamy; Tanecia Mitchell; Cheryl Lichti; Judit Megyesi; Lee Ann MacMillan-Crow
Journal:  Free Radic Biol Med       Date:  2007-02-28       Impact factor: 7.376

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.